LensOne enters pivotal study as Long Bridge Medical targets a difficult gap in secondary IOL fixation
Long Bridge Medical’s LensOne has entered a pivotal FDA-cleared study. Read why this ophthalmic device trial could reshape secondary IOL fixation.
Long Bridge Medical’s LensOne has entered a pivotal FDA-cleared study. Read why this ophthalmic device trial could reshape secondary IOL fixation.